A dedicated new cancer service is set to deliver more personalised, efficient and streamlined care at University Hospitals of North Midlands NHS Trust.
Those suffering from thrombosis residing in the Staffordshire and Stoke-on-Trent regions will now have access to the new service at Royal Stoke University Hospital that has been launched to help the approximate 20% of cancer patients that are at an increased risk of developing the condition.
The innovative Cancer Associated Thrombosis (CAT) clinic has been developed in collaboration with University Hospitals of North Midlands’s oncology team and the Staffordshire Thrombosis Anticoagulation Service. It will combine the expertise from oncologists, general practitioners, clinicians and surgeons in one place, ultimately speeding up treatment processes, improving patient care and thus their health outcomes.
Dr Shahid Gilani, Specialist doctor in Clinical Oncology said: “Cancer is the highest single risk factor for thrombosis therefore the CAT Clinic will play an important role in improving both the outcomes and quality of life in these patients.
“We now have a dedicated team to manage cancer patients with thrombosis and in need of anticoagulation ensuring that patients get assessed, diagnosed and treated quickly. We are also able to provide patient education and support, something vital as part of the recovery process.”
The NHS continues to deliver innovative new methods of cancer care with this dedicated new service being just the latest.
In the latest edition of our online magazine, we explored a pioneering new procedure for oesophageal cancer patients – click here to read all about it.
